Tudorza pressair and Feeling jittery - a phase IV clinical study of FDA data

Summary:

Feeling jittery is reported as a side effect among people who take Tudorza pressair (aclidinium bromide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Symbicort,.

The phase IV clinical study analyzes which people have Feeling jittery when taking Tudorza pressair. It is created by eHealthMe based on reports of 6,285 people who have side effects when taking Tudorza pressair from the FDA, and is updated regularly.

What is Tudorza pressair?

Tudorza pressair has active ingredients of aclidinium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 6,309 Tudorza pressair users. Check the latest studies of Tudorza pressair.

What is Feeling jittery?

Feeling jittery is found to be associated with 1,106 drugs and 1,128 conditions by eHealthMe. Check the latest studies of Feeling jittery.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 24, 2026

6,285 people reported to have side effects when taking Tudorza pressair.
Among them, 17 people (0.27%) have Feeling jittery.

Could Tudorza pressair cause Feeling jittery?

Among these 17 people:

How long have people been on Tudorza pressair when they have Feeling jittery? *

What is the gender of people who have Feeling jittery when taking Tudorza pressair? *

female: 76.47 %
male: 23.53 %

What is the age of people who have Feeling jittery when taking Tudorza pressair? *

What are other drugs people take besides Tudorza pressair? *

What are other side effects people have besides Feeling jittery? *

Body Height Decreased: 4 people, 23.53%
Irritable Bowel Syndrome: 4 people, 23.53%
Gait Disturbance: 3 people, 17.65%
Dyspnea (difficult or laboured breathing): 3 people, 17.65%
Hoarseness Or Changing Voice: 2 people, 11.76%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 11.76%
Memory Loss: 2 people, 11.76%
Weight Decreased: 2 people, 11.76%
Hypotension (abnormally low blood pressure): 2 people, 11.76%
Hypersensitivity: 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Tudorza pressair and have Feeling jittery?

- Check whether Feeling jittery is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tudorza pressair:

Tudorza pressair (6,309 reports)

Feeling jittery treatments and more:

Feeling jittery (21,911 reports)

Browse all side effects of Tudorza pressair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Feeling jittery:

Feeling jittery (1,106 drugs)

Browse all the conditions that are associated with Feeling jittery:

Feeling jittery (1,128 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aclidinium bromide (the active ingredients of Tudorza pressair) and Tudorza pressair (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.